MedTrace Logo

Safety and Efficacy of EUS-RFA in Pancreatic Insulinoma

NCT07585032 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 20

Last updated 2026-05-13

No results posted yet for this study

Summary

Transcutaneous and EUS-guided radiofrequency ablation are both modern modalities to apply in the managemnet of various malignancies.

In the current study the investigators aim to study the technical feasibility, patient safety and clinical efficacy of EUS-RFA for the treatment of pancreatic insulinoma.

Conditions

  • Insulinoma; Pancreas

Interventions

PROCEDURE

EUS-RFA

Treatment of insulinoma by EUS-RFA

Sponsors & Collaborators

  • Sahlgrenska University Hospital

    lead OTHER

Eligibility

Min Age
15 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-03-31
Primary Completion
2028-12-31
Completion
2029-06-30

Countries

  • Sweden

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07585032 on ClinicalTrials.gov